Short Research Communication Anti-Spike Antibody Response to COVISHIELD ™ (SII-ChAdOx1 nCoV-19) Vaccine in Patients with B-Cell and Plasma Cell Malignancies and Hematopoietic Cell Transplantation Recipients

ConclusionsThis study confirms the safety and efficacy of the COVISHIELD ™ vaccine in patients with hematological malignancies.
Source: Indian Journal of Hematology and Blood Transfusion - Category: Hematology Source Type: research